Path ID: DB09331_MESH_D009101_1

Concepts
Identifier | Name | Type |
---|---|---|
MESH:C556306 | daratumumab | Drug |
UniProt:P28907 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | Protein |
GO:0016049 | cell growth | BiologicalProcess |
GO:0006915 | apoptotic process | BiologicalProcess |
GO:0042100 | B cell proliferation | BiologicalProcess |
MESH:D009101 | Multiple myeloma | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
Subject | Predicate | Object |
---|---|---|
Daratumumab | DECREASES ACTIVITY OF | Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1 |
Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1 | NEGATIVELY REGULATES | Apoptotic Process |
Apoptotic Process | NEGATIVELY CORRELATED WITH | Multiple Myeloma |
Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1 | POSITIVELY REGULATES | Cell Growth |
Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1 | POSITIVELY REGULATES | B Cell Proliferation |
Cell Growth | POSITIVELY CORRELATED WITH | Multiple Myeloma |
B Cell Proliferation | POSITIVELY CORRELATED WITH | Multiple Myeloma |
Reference: